Back
Clinuvel Pharmaceuticals Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
20
CLVLY
Clinuvel Pharmaceuticals
Last Price:
7.91
Seasonality Move:
0.71%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...Clinuvel Pharmaceuticals Price Quote
$7.91
+0.00 (+1.02%)
(Updated: December 14, 2024 at 5:28 AM ET)
Clinuvel Pharmaceuticals Key Stats
Sell
20
Clinuvel Pharmaceuticals (CLVLY)
is a Sell
Day range:
$7.83 - $8.05
52-week range:
$7.83 - $11.43
Dividend yield:
0.43%
P/E ratio:
17.28
P/S ratio:
6.97
P/B ratio:
2.92%
Volume:
2.5K
Avg. volume:
3.2K
1-year change:
-28.78%
Market cap:
$395.7M
Revenue:
$57.8M
EPS:
$0.46
How Much Does Clinuvel Pharmaceuticals Make?
-
How Much Are Clinuvel Pharmaceuticals's Sales Annually?
CLVLY Revenues are $57.8M -
How Much Profit Does Clinuvel Pharmaceuticals's Make A Year?
CLVLY net income is $23.4M
Is Clinuvel Pharmaceuticals Growing As A Company?
Data Unavailable
Clinuvel Pharmaceuticals Stock Price Performance
-
Did Clinuvel Pharmaceuticals Stock Go Up Last Month?
Clinuvel Pharmaceuticals share price went down by -11.68% last month -
Did CLVLY's Share Price Rise Over The Last Year?
CLVLY share price fell by -28.78% over the past 1 year
What Is Clinuvel Pharmaceuticals 52-Week High & Low?
-
What Is Clinuvel Pharmaceuticals’s 52-Week High Share Price?
Clinuvel Pharmaceuticals has traded as high as $11.43 over the past 52 weeks -
What Is Clinuvel Pharmaceuticals’s 52-Week Low Share Price?
Clinuvel Pharmaceuticals has traded as low as $7.83 over the past 52 weeks
Clinuvel Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Clinuvel Pharmaceuticals?
-
How Much Debt Does Clinuvel Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Clinuvel Pharmaceuticals Have?
Cash and short term investments quarterly total is $122.9M -
What Is Clinuvel Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.71
Is Clinuvel Pharmaceuticals Cash Flow Positive?
Data Unavailable
Clinuvel Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CLVLY return on invested capital is 19.13% -
What Is Clinuvel Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 16.45% -
What Is CLVLY Return On Equity?
ROE is a measure of profitability and is 19.16%
Clinuvel Pharmaceuticals Earnings Date & Stock Price
-
What Is Clinuvel Pharmaceuticals's Stock Price Today?
A single share of CLVLY can be purchased today for 7.91 -
What Is Clinuvel Pharmaceuticals’s Stock Symbol?
Clinuvel Pharmaceuticals trades on the otcm under the ticker symbol: CLVLY -
When Is Clinuvel Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Clinuvel Pharmaceuticals is scheduled on February 28, 2025 -
When Is CLVLY's next ex-dividend date?
Clinuvel Pharmaceuticals's next ex-dividend date is September 9, 2024 -
How To Buy Clinuvel Pharmaceuticals Stock?
You can buy Clinuvel Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Clinuvel Pharmaceuticals Competitors
-
Who Are Clinuvel Pharmaceuticals's Competitors?
Below is a list of companies who compete with Clinuvel Pharmaceuticals or are related in some way:
Clinuvel Pharmaceuticals Dividend Yield
-
What Is CLVLY Dividend Yield?
Clinuvel Pharmaceuticals’s dividend yield currently is 0.43% -
What Is Clinuvel Pharmaceuticals’s Payout Ratio?
Clinuvel Pharmaceuticals’s payout ratio is 6.87% -
When Did Clinuvel Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is December 14, 2024 -
What Is Clinuvel Pharmaceuticals’s Dividend Per Share?
Clinuvel Pharmaceuticals pays a dividend of $0.00 per share
Clinuvel Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |